Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 34

    1.

    Images in clinical medicine. Tophaceous gout.

    Samaras N, Rossi C.

    N Engl J Med. 2012 Jan 19;366(3):e6. No abstract available.

    PMID:
    22256825
    [PubMed - indexed for MEDLINE]
    Free Article
    2.

    Long interdialytic interval and mortality.

    van Stralen KJ, Wanner C, Jager KJ.

    N Engl J Med. 2011 Dec 22;365(25):2437; author reply 2437-8. No abstract available.

    PMID:
    22188001
    [PubMed - indexed for MEDLINE]
    3.

    Long interdialytic interval and mortality.

    Doorenbos CJ.

    N Engl J Med. 2011 Dec 22;365(25):2437; author reply 2437-8. No abstract available.

    PMID:
    22188000
    [PubMed - indexed for MEDLINE]
    4.

    Long interdialytic interval and mortality.

    Pazmiño PA.

    N Engl J Med. 2011 Dec 22;365(25):2436-7; author reply 2437-8. No abstract available.

    PMID:
    22187999
    [PubMed - indexed for MEDLINE]
    5.

    Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.

    DCCT/EDIC Research Group, de Boer IH, Sun W, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Zinman B.

    N Engl J Med. 2011 Dec 22;365(25):2366-76. Epub 2011 Nov 12.

    PMID:
    22077236
    [PubMed - indexed for MEDLINE]
    6.

    Bardoxolone methyl, chronic kidney disease, and type 2 diabetes.

    McMahon GM, Forman JP.

    N Engl J Med. 2011 Nov 3;365(18):1746; author reply 1746-7. No abstract available.

    PMID:
    22047581
    [PubMed - indexed for MEDLINE]
    7.

    Bardoxolone methyl, chronic kidney disease, and type 2 diabetes.

    Upadhyay A, Sarnak MJ, Levey AS.

    N Engl J Med. 2011 Nov 3;365(18):1746; author reply 1746-7. No abstract available.

    PMID:
    22047580
    [PubMed - indexed for MEDLINE]
    8.

    Bardoxolone methyl, chronic kidney disease, and type 2 diabetes.

    Rogacev KS, Bittenbring JT, Fliser D.

    N Engl J Med. 2011 Nov 3;365(18):1745-6; author reply 1746-7. No abstract available.

    PMID:
    22047579
    [PubMed - indexed for MEDLINE]
    9.

    Bardoxolone methyl, chronic kidney disease, and type 2 diabetes.

    Van Laecke S, Vanholder R.

    N Engl J Med. 2011 Nov 3;365(18):1745; author reply 1746-7. No abstract available.

    PMID:
    22047578
    [PubMed - indexed for MEDLINE]
    10.

    Desensitization of HLA-incompatible kidney recipients.

    Bayry J, Kaveri SV.

    N Engl J Med. 2011 Oct 27;365(17):1644; author reply 1644-5. No abstract available.

    PMID:
    22029994
    [PubMed - indexed for MEDLINE]
    11.

    Desensitization of HLA-incompatible kidney recipients.

    Morath C, Zeier M, Süsal C.

    N Engl J Med. 2011 Oct 27;365(17):1644; author reply 1644-5. No abstract available.

    PMID:
    22029993
    [PubMed - indexed for MEDLINE]
    12.

    Desensitization of HLA-incompatible kidney recipients.

    Huber L, Naik M, Budde K.

    N Engl J Med. 2011 Oct 27;365(17):1643; author reply 1644-5. No abstract available.

    PMID:
    22029992
    [PubMed - indexed for MEDLINE]
    13.

    Long interdialytic interval and mortality among patients receiving hemodialysis.

    Foley RN, Gilbertson DT, Murray T, Collins AJ.

    N Engl J Med. 2011 Sep 22;365(12):1099-107.

    PMID:
    21992122
    [PubMed - indexed for MEDLINE]
    Free Article
    14.

    Desensitization in HLA-incompatible kidney recipients and survival.

    Montgomery RA, Lonze BE, King KE, Kraus ES, Kucirka LM, Locke JE, Warren DS, Simpkins CE, Dagher NN, Singer AL, Zachary AA, Segev DL.

    N Engl J Med. 2011 Jul 28;365(4):318-26.

    PMID:
    21793744
    [PubMed - indexed for MEDLINE]
    Free Article
    15.

    Survivors--dialysis, immigration, and U.S. law.

    Raghavan R, Nuila R.

    N Engl J Med. 2011 Jun 9;364(23):2183-5. No abstract available.

    PMID:
    21651391
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    Alemtuzumab induction in renal transplantation.

    Hanaway MJ, Woodle ES, Mulgaonkar S, Peddi VR, Kaufman DB, First MR, Croy R, Holman J; INTAC Study Group.

    N Engl J Med. 2011 May 19;364(20):1909-19.

    PMID:
    21591943
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Dialysis catheters and recombinant tissue plasminogen activator.

    Allon M.

    N Engl J Med. 2011 May 5;364(18):1779; author reply 1779-80. No abstract available.

    PMID:
    21542758
    [PubMed - indexed for MEDLINE]
    18.

    Frequent versus standard hemodialysis.

    Blagg CR.

    N Engl J Med. 2011 Mar 10;364(10):974; author reply 976. No abstract available.

    PMID:
    21388321
    [PubMed - indexed for MEDLINE]
    19.

    Frequent versus standard hemodialysis.

    Laskin B, Mitsnefes M.

    N Engl J Med. 2011 Mar 10;364(10):974-5; author reply 976. No abstract available.

    PMID:
    21388320
    [PubMed - indexed for MEDLINE]
    20.

    Frequent versus standard hemodialysis.

    Badve SV, Hawley CM, Johnson DW.

    N Engl J Med. 2011 Mar 10;364(10):975; author reply 976. No abstract available.

    PMID:
    21388319
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk